167 related articles for article (PubMed ID: 17691212)
21. Evaluating the utility of ion mobility separation in combination with high-pressure liquid chromatography/mass spectrometry to facilitate detection of trace impurities in formulated drug products.
Eckers C; Laures AM; Giles K; Major H; Pringle S
Rapid Commun Mass Spectrom; 2007; 21(7):1255-63. PubMed ID: 17340559
[TBL] [Abstract][Full Text] [Related]
22. Alternatives to amino acid analysis for the purity control of pharmaceutical grade L-alanine.
Holzgrabe U; Nap CJ; Beyer T; Almeling S
J Sep Sci; 2010 Aug; 33(16):2402-10. PubMed ID: 20549666
[TBL] [Abstract][Full Text] [Related]
23. Use of a quality-by-design approach to justify removal of the HPLC weight % assay from routine API stability testing protocols.
Skrdla PJ; Wang T; Antonucci V; Dowling T; Ge Z; Ellison D; Curran J; Mohan G; Wyvratt J
J Pharm Biomed Anal; 2009 Dec; 50(5):794-6. PubMed ID: 19596534
[TBL] [Abstract][Full Text] [Related]
24. Sensitive quantification of chosen drugs by reversed-phase chromatography with electrochemical detection at a glassy carbon electrode.
Chmielewska A; Konieczna L; Plenis A; Lamparczyk H
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jul; 839(1-2):102-11. PubMed ID: 16716774
[TBL] [Abstract][Full Text] [Related]
25. Determination of phenothiazine derivatives by high performance thin-layer chromatography combined with densitometry.
Wójciak-Kosior M; Skalska A; Matysik A
J Pharm Biomed Anal; 2006 Apr; 41(1):286-9. PubMed ID: 16321493
[TBL] [Abstract][Full Text] [Related]
26. Development of a validated RP-LC/ESI-MS-MS method for separation, identification and determination of related substances of tamsulosin in bulk drugs and formulations.
Nageswara Rao R; Kumar Talluri MV; Narasa Raju A; Shinde DD; Ramanjaneyulu GS
J Pharm Biomed Anal; 2008 Jan; 46(1):94-103. PubMed ID: 17951020
[TBL] [Abstract][Full Text] [Related]
27. Analytical methods for residual solvents determination in pharmaceutical products.
Grodowska K; Parczewski A
Acta Pol Pharm; 2010; 67(1):13-26. PubMed ID: 20210075
[TBL] [Abstract][Full Text] [Related]
28. Improving the detection of degradants and impurities in pharmaceutical drug products by applying mass spectral and chromatographic searching.
Freed AL; Kale U; Ando H; Rossi DT; Kingsmill CA
J Pharm Biomed Anal; 2004 Jun; 35(4):727-38. PubMed ID: 15193717
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous LC determination of some antidepressants combined with neuroleptics.
Karpinska J; Starczewska B
J Pharm Biomed Anal; 2002 Jul; 29(3):519-25. PubMed ID: 12062652
[TBL] [Abstract][Full Text] [Related]
30. Rapid microsample analysis of imipramine and desipramine by reversed-phase high-performance liquid chromatography with ultraviolet detection.
Yoo SD; Holladay JW; Fincher TK; Dewey MJ
J Chromatogr B Biomed Appl; 1995 Jun; 668(2):338-42. PubMed ID: 7581871
[TBL] [Abstract][Full Text] [Related]
31. Development and validation of a reversed-phase liquid chromatographic method for analysis of degradation products of estradiol in Vagifem tablets.
Nygaard L; Drøhse Kilde H; Andersen SG; Henriksen L; Overby V
J Pharm Biomed Anal; 2004 Feb; 34(2):265-76. PubMed ID: 15013140
[TBL] [Abstract][Full Text] [Related]
32. Development and validation of a method for the purity determination of (3beta,20R)-4,4-dimethylcholesta-8,14,24-trien-3-ol(FF-MAS) in pharmaceutical products containing recombinant human albumin.
Jamali B; Andersen SG; Brødholt H; Wendel L; Bødstrup V
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(2):251-7. PubMed ID: 15380722
[TBL] [Abstract][Full Text] [Related]
33. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
Lalitha Devi M; Chandrasekhar KB
J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
[TBL] [Abstract][Full Text] [Related]
34. Stability-indicating HPTLC determination of imatinib mesylate in bulk drug and pharmaceutical dosage form.
Vadera N; Subramanian G; Musmade P
J Pharm Biomed Anal; 2007 Jan; 43(2):722-6. PubMed ID: 16920319
[TBL] [Abstract][Full Text] [Related]
35. [Estimation of impurity profiles of drugs and related materials. 20. Methodological problems in the identification and determination of organic impurities].
Görög S
Acta Pharm Hung; 2000; 70(3-6):131-7. PubMed ID: 11379019
[TBL] [Abstract][Full Text] [Related]
36. Reversed phase ion-pair high performance liquid chromatographic gradient separation of related impurities in 2,4-disulfonic acid benzaldehyde di-sodium salt.
Lu B; Jonsson P; Blomberg S
J Chromatogr A; 2006 Jun; 1119(1-2):270-6. PubMed ID: 16378614
[TBL] [Abstract][Full Text] [Related]
37. A validated reversed phase HPLC method for the determination of process-related impurities in almotriptan malate API.
Kumar AP; Ganesh VR; Rao DV; Anil C; Rao BV; Hariharakrishnan VS; Suneetha A; Sundar BS
J Pharm Biomed Anal; 2008 Mar; 46(4):792-8. PubMed ID: 18191357
[TBL] [Abstract][Full Text] [Related]
38. Development of an HPLC method for the monitoring of tricyclic antidepressants in biofluids.
Samanidou VF; Nika MK; Papadoyannis IN
J Sep Sci; 2007 Oct; 30(15):2391-400. PubMed ID: 17625794
[TBL] [Abstract][Full Text] [Related]
39. Validation of a high-performance liquid chromatographic method for the simultaneous determination of tramadol and its impurities in oral drops as a pharmaceutical formulation.
Zecević M; Stanković Z; Zivanović Lj; Jocić B
J Chromatogr A; 2006 Jun; 1119(1-2):251-6. PubMed ID: 16386751
[TBL] [Abstract][Full Text] [Related]
40. Control of impurities in diphenhydramine hydrochloride by an ion-pairing, reverse liquid chromatography method.
Henderson L; Miller JH; Skellern GG
J Pharm Pharmacol; 2001 Mar; 53(3):323-31. PubMed ID: 11291747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
